HIKMA PHARMACEUTICALS ORD GBP0.10 revenue for the last year amounted to 2.52 B GBP, the most of which — 1.02 B GBP — came from its highest performing source at the moment, Injectables, the year earlier bringing 967.78 M GBP. The greatest contribution to the revenue figure was made by United States — last year it brought HIKMA PHARMACEUTICALS ORD GBP0.10 1.48 B GBP, and the year before that — 1.39 B GBP.